(VCBeat) Mar. 22, 2021 -- On March 22, 2021, Hangzhou Jianhai Technology Co., Ltd. ( "JustHealth Technology") today announced it has closed ¥150 million in Series B funding, led by Sequoia Capital China with participation from Source Code Capital and Sherpa Venture Capital. Probe Capital acted as the exclusive financial advisor in the latest round.
Founded in 2015, JustHealth Technology focuses on post-diagnosis disease management and services. Currently, it has cooperated with more than 1,000 hospitals. Adhering to the concept of "making care a good prescription", JustHealth Technology is committed to promoting the construction of post-diagnosis disease management system for patients, so as to give them safer medical services and a better life.
The fresh round of funding will be used towards the construction of the post-diagnosis management system of diseases and the ecosystem for service operation.
JustHealth Technology has explored the medical diagnosis field for a long time. For clinical disease management after diagnosis, the company has launched three series of products to complete the infrastructure construction of post-diagnosis disease management in hospitals, namely "C.S.D". The C series is for the co-construction of disease management services. The S series is the smart patient service platform. The D series is a digital therapy platform.
About Sequoia Capital China
Sequoia Capital China, as the "entrepreneur behind entrepreneur", focuses on investment in four directions including technology/media, healthcare, consumer goods/modern services and industrial technology. Over the past 15 years, Sequoia Capital China has invested in nearly 600 enterprises with distinctive technical characteristics, innovative business models, and high growth and development potential.
About Source Code Capital
Since inception in 2014, Source Code Capital has been committed to becoming the partner of choice for leading entrepreneurs in today's Information Revolution era with USD $1.5 billion and RMB 8.8 billion under management.
Source Code Capital invests across both early and growth stages. It is focused on the "Big 3" fundamental drivers, which are Internet+, AI+, and Global+ (China-angle companies in the international arena), and invest in sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.